Home › Immune System and Disorders › District of Columbia
Immune System and Disorders clinical trials in District of Columbia
3 studies for Immune System and Disorders are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.